The cerebellum and migraine

Headache

Volumn 47, Issue 6, 2007, Pages 820-833

  Vincent, Maurice ^a,d   Hadjikhani, Nouchine ^b,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d NONE   (Brazil)

Author keywords

Cerebellum; Episodic ataxia; Familial hemiplegic migraine; Migraine; Progressive ataxia

Indexed keywords

ACETAZOLAMIDE; CALCIUM CHANNEL; EXCITATORY AMINO ACID TRANSPORTER 1; GENE PRODUCT; ION CHANNEL; PLACEBO; PROTEIN ATP1A2; PROTEIN CACNA1A; PROTEIN SCN1A; SUMATRIPTAN; TOPIRAMATE; UNCLASSIFIED DRUG;

ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; BASILAR ARTERY; BRAIN CIRCULATION; BRAIN DEPTH STIMULATION; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CEREBELLUM DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMA; CONSCIOUSNESS DISORDER; DIPLOPIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG WITHDRAWAL; DYSARTHRIA; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENETIC ASSOCIATION; HEADACHE; HUMAN; HYPOACUSIS; MEDICAL LITERATURE; MIGRAINE; MIGRAINE AURA; NONHUMAN; PARESTHESIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; REVIEW; SPINOCEREBELLAR DEGENERATION; SPREADING CORTICAL DEPRESSION; TINNITUS; UNSPECIFIED SIDE EFFECT; VERTIGO; VESTIBULAR DISORDER; VISUAL DISORDER; WAVEFORM;

ANIMALS; ATAXIA; CEREBELLUM; HUMANS; MIGRAINE DISORDERS;

EID: 34250669263     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00715.x     Document Type: Review

References (154)

1. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 6 : 429 440.
2. Goadsby PJ. Migraine: Diagnosis and management. Intern Med J. 2003 33 : 436 442.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004 24 (suppl 1).
4. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002 346 : 257 270.
5. Parsons AA, Strijbos PJ. The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol. 2003 3 : 73 77.
6. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981 9 : 344 352.
7. Welch KM. Brain hyperexcitability: The basis for antiepileptic drugs in migraine prevention. Headache. 2005 45 (suppl 1 S25 S32.
8. Haan J, Kors EE, Vanmolkot KR, van den Maagdenberg AM, Frants RR, Ferrari MD. Migraine genetics: An update. Curr Pain Headache Rep. 2005 9 : 213 220.
9. Young WB, Oshinsky ML, Shechter AL, Gebeline-Myers C, Bradley KC, Wassermann EM. Consecutive transcranial magnetic stimulation: Phosphene thresholds in migraineurs and controls. Headache. 2004 44 : 131 135.
10. Trachtenberg MC, Hull CD, Buchwald NA. Electrophysiological concomitants of spreading depression in caudate and thalamic nuclei of the cat. Brain Res. 1970 20 : 219 231.
11. Vinogradova LV, Koroleva VI, Bures J. Re-entry waves of Leao's spreading depression between neocortex and caudate nucleus. Brain Res. 1991 538 : 161 164.
12. Leão AAP, Martins-Ferreira H. Nota acerca da depressão alastrante no cerebelo, tubérculo quadrigêmino anterior e bulbo olfativo. An Acad Bras Cienc. 1961 22 : 34 40.
13. Fifková E, Bures J, Koshtoyants OK, Krivánek J. T.W. Leão's spreading depression in the cerebellum of the rat. Experientia. 1961 17 : 572 573.
14. Young W. Spreading depression in elasmobranch cerebellum. Brain Res. 1980 199 : 113 126.
15. Nicholson C. Comparative neurophysiology of spreading depression in the cerebellum. An Acad Bras Cienc. 1984 56 : 481 494.
16. Martins-Ferreira H, de Oliveira Castro G, Struchiner CJ, Rodrigues PS. Circling spreading depression in isolated chick retina. J Neurophysiol. 1974 37 : 773 784.
17. Martins-Ferreira H, de Oliveira Castro G. Spreading depression in isolated chick retina. Vision Res. 1971 11 (suppl 3 71 84.
18. Martins-Ferreira H. Depressão alastrante na retina. An Acad Bras Cienc. 1962 34 : 44.
19. Martins-Ferreira H. Spreading depression in the chicken retina. In : Ookawa T, ed. The Brain and Behavior of the Fowl. 1st ed. Tokyo : Japan Scientific Societies Press 1983 : 317 333.
20. Maranhão-Filho PA, Martins-Ferreira H, Vincent MB, Ribeiro LJ, Novis SA. Sumatriptan blocks spreading depression in isolated chick retina. Cephalalgia. 1997 17 : 822 825.
21. Martins-Ferreira H. Propagation of spreading depression in isolated chick retina. In : Lehmenkühler A, Grotemaier KH, Tegtmeier F, eds. Migraine: Basic Mechanisms and Treatment. Monchen. Wien, Baltimore : Urban and Schwarzenberg 1993 : 533 546.
22. do Carmo RJ, Martins-Ferreira H. Spreading depression of Leao probed with ion-selective microelectrodes in isolated chick retina. An Acad Bras Cienc. 1984 56 : 401 421.
23. Streit DS, Ferreira Filho CR, Martins-Ferreira H. Spreading depression in isolated spinal cord. J Neurophysiol. 1995 74 : 888 890.
24. Leão AAP, Morison RS. Propagation of spreading cortical depression. J Neurophysiol. 1945 8 : 33 45.
25. Leão AAP. Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944 7 : 391 396.
26. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev. 2005 48 : 438 456.
27. Hadjikhani N, Sanchez Del Rio M, Wu O, et al Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001 98 : 4687 4692.
28. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993 13 : 1167 1177.
29. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984 16 : 157 168.
30. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol. 1990 99 : 202 209.
31. Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia. 1991 11 : 165 168.
32. Jansen I, Edvinsson L, Mortensen A, Olesen J. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia. 1992 12 : 202 205.
33. Barlow JS. The Cerebellum and Adaptative Control. New York : Cambridge University Press 2002.
34. Schmahmann JD. Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2004 16 : 367 378.
35. Goldowitz D, Hamre K. The cells and molecules that make a cerebellum. Trends Neurosci. 1998 21 : 375 382.
36. Ishizaki K, Mori N, Takeshima T, et al Static stabilometry in patients with migraine and tension-type headache during a headache-free period. Psychiatry Clin Neurosci. 2002 56 : 85 90.
37. Cho AA, Clark JB, Rupert AH. Visually triggered migraine headaches affect spatial orientation and balance in a helicopter pilot. Aviat Space Environ Med. 1995 66 : 353 358.
38. Harno H, Hirvonen T, Kaunisto MA, et al Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology. 2003 61 : 1748 1752.
39. Sandor PS, Mascia A, Seidel L, de Pasqua V, Schoenen J. Subclinical cerebellar impairment in the common types of migraine: A three-dimensional analysis of reaching movements. Ann Neurol. 2001 49 : 668 672.
40. Baloh RW. Neurotology of migraine. Headache. 1997 37 : 615 621.
41. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992 32 : 300 304.
42. Toglia JU, Thomas D, Kuritzky A. Common migraine and vestibular function. Electronystagmographic study and pathogenesis. Ann Otol Rhinol Laryngol. 1981 90 (3pt1 267 271.
43. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984 107 (pt4 1123 1142.
44. Guerraz M, Yardley L, Bertholon P, et al Visual vertigo: Symptom assessment, spatial orientation and postural control. Brain. 2001 124 (pt8 1646 1656.
45. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual dysfunction between migraine events. Invest Ophthalmol Vis Sci. 2001 42 : 626 633.
46. McKendrick AM, Badcock DR. Motion processing deficits in migraine. Cephalalgia. 2004 24 : 363 372.
47. Yenice O, Onal S, Incili B, Temel A, Afsar N, Tanrida Gcaron T. Assessment of spatial-contrast function and short-wavelength sensitivity deficits in patients with migraine. Eye. 2006.
48. Polak O, Grof P. Kleinhirnmigräne bei basilarer impression. Psychiatr Neurol (Basel). 1966 152 : 246 257.
49. Heidrich R. Cerebellar migraine. Psychiatr Neurol Med Psychol (Leipz). 1961 13 : 42 46.
50. Chrást B. Migraena cerebellaris. Bratisl Lékarskék Listy. 1954 9 : 271 276.
51. Bickerstaff ER. Basilar artery migraine. Lancet. 1961 277 : 15 17.
52. Golden GS, French JH. Basilar artery migraine in young children. Pediatrics. 1975 56 : 722 726.
53. Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine. Clinical, epidemiologic and genetic features. Neurology. 2006 66 : 880 886.
54. Bernsen HJ, Van de Vlasakker C, Verhagen WI, Prick MJ. Basilar artery migraine stroke. Headache. 1990 30 : 142 144.
55. Sabharwal RK, Mehndiratta MM, Gupta M, Anjaneyulu A, Malhotra LK, Khwaja G. Cerebellar and thalamic infarctions in basilar artery migraine. J Assoc Physicians India. 1990 38 : 237 238.
56. Ganji S, Williams W, Furlow J. Bilateral occipital lobe infarction in acute migraine: Clinical, neurophysiological, and neuroradiological study. Headache. 1992 32 : 360 365.
57. Seto H, Shimizu M, Futatsuya R, et al Basilar artery migraine. Reversible ischemia demonstrated by Tc-99m HMPAO brain SPECT. Clin Nucl Med. 1994 19 : 215 218.
58. Muellbacher W, Mamoli B. Prolonged impaired consciousness in basilar artery migraine. Headache. 1994 34 : 282 285.
59. Ambrosini A, D'Onofrio M, Grieco GS, et al Familial basilar migraine associated with a new mutation in the ATP1A 2 gene. Neurology. 2005 65 : 1826 1828.
60. Kors EE, Haan J, Giffin NJ, et al Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: A description of 5 families with familial hemiplegic migraine. Arch Neurol. 2003 60 : 684 688.
61. Ophoff RA, Terwindt GM, Vergouwe MN, et al Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996 87 : 543 552.
62. Ducros A, Joutel A, Vahedi K, et al Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997 42 : 885 890.
63. Vanmolkot KR, Kors EE, Hottenga JJ, et al Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003 54 : 360 366.
64. Dichgans M, Freilinger T, Eckstein G, et al Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005 366 : 371 377.
65. Spadaro M, Ursu S, Lehmann-Horn F, et al A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics. 2004 5 : 177 185.
66. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature. 1992 355 : 827 829.
67. Mori Y, Friedrich T, Kim MS, et al Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature. 1991 350 : 398 402.
68. Dunlap K, Luebke JI, Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci. 1995 18 : 89 98.
69. Pineda JC, Waters RS, Foehring RC. Specificity in the interaction of HVA Ca2+ channel types with Ca2+-dependent AHPs and firing behavior in neocortical pyramidal neurons. J Neurophysiol. 1998 79 : 2522 2534.
70. Hans M, Luvisetto S, Williams ME, et al Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci. 1999 19 : 1610 1619.
71. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004 41 : 701 710.
72. Ducros A, Denier C, Joutel A, et al Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet. 1999 64 : 89 98.
73. Vahedi K, Denier C, Ducros A, et al CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology. 2000 55 : 1040 1042.
74. Battistini S, Stenirri S, Piatti M, et al A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology. 1999 53 : 38 43.
75. Margolis RL. The spinocerebellar ataxias: Order emerges from chaos. Curr Neurol Neurosci Rep. 2002 2 : 447 456.
76. Hawkes CH. Familial paroxysmal ataxia: Report of a family. J Neurol Neurosurg Psychiatry. 1992 55 : 212 213.
77. Harada H, Tamaoka A, Watanabe M, Ishikawa K, Shoji S. Downbeat nystagmus in two siblings with spinocerebellar ataxia type 6 (SCA 6). J Neurol Sci. 1998 160 : 161 163.
78. Friend KL, Crimmins D, Phan TG, et al Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum Genet. 1999 105 : 261 265.
79. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004 62 : 17 22.
80. Denier C, Ducros A, Durr A, Eymard B, Chassande B, Tournier-Lasserve E. Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol. 2001 58 : 292 295.
81. Guida S, Trettel F, Pagnutti S, et al Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet. 2001 68 : 759 764.
82. Kvistad PH, Dahl A, Skre H. Autosomal recessive non-progressive ataxia with an early childhood debut. Acta Neurol Scand. 1985 71 : 295 302.
83. Tranebjaerg L, Teslovich TM, Jones M, et al Genome-wide homozygosity mapping localizes a gene for autosomal recessive non-progressive infantile ataxia to 20q11-q13. Hum Genet. 2003 113 : 293 295.
84. Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology. 2001 57 : 1499 1502.
85. Mantuano E, Veneziano L, Jodice C, Frontali M. Spinocerebellar ataxia type 6 and episodic ataxia type 2: Differences and similarities between two allelic disorders. Cytogenet Genome Res. 2003 100 : 147 153.
86. Frontali M. Spinocerebellar ataxia type 6: Channelopathy or glutamine repeat disorder? Brain Res Bull. 2001 56 : 227 231.
87. Jen J. Familial episodic ataxias and related ion channel disorders. Curr Treat Options Neurol. 2000 2 : 429 431.
88. Jodice C, Mantuano E, Veneziano L, et al Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet. 1997 6 : 1973 1978.
89. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology. 2005 65 : 529 534.
90. Zhuchenko O, Bailey J, Bonnen P, et al Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 15 : 62 69.
91. Alonso I, Barros J, Tuna A, et al Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. Arch Neurol. 2003 60 : 610 614.
92. Alonso I, Barros J, Tuna A, et al A novel R1347Q mutation in the predicted voltage sensor segment of the P/Q-type calcium-channel alpha-subunit in a family with progressive cerebellar ataxia and hemiplegic migraine. Clin Genet. 2004 65 : 70 72.
93. Richter S, Dimitrova A, Maschke M, et al Degree of cerebellar ataxia correlates with three-dimensional MRI-based cerebellar volume in pure cerebellar degeneration. Eur Neurol. 2005 54 : 23 27.
94. Ducros A, Denier C, Joutel A, et al The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001 345 : 17 24.
95. Elliott MA, Peroutka SJ, Welch S, May EF. Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol. 1996 39 : 100 106.
96. Kors EE, Melberg A, Vanmolkot KR, et al Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology. 2004 63 : 1136 1137.
97. Jen J, Yue Q, Nelson SF, et al A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia. Neurology. 1999 53 : 34 37.
98. Nam SC, Hockberger PE. Analysis of spontaneous electrical activity in cerebellar Purkinje cells acutely isolated from postnatal rats. J Neurobiol. 1997 33 : 18 32.
99. Walter JT, Alvina K, Womack MD, Chevez C, Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci. 2006 9 : 389 397.
100. Kors EE, Terwindt GM, Vermeulen FL, et al Delayed cerebral edema and fatal coma after minor head trauma: Role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol. 2001 49 : 753 760.
101. Fitzsimons RB, Wolfenden WH. Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain. 1985 108 (pt3 555 577.
102. Munte TF, Muller-Vahl H. Familial migraine coma: A case study. J Neurol. 1990 237 : 59 61.
103. Wada T, Kobayashi N, Takahashi Y, Aoki T, Watanabe T, Saitoh S. Wide clinical variability in a family with a CACNA1A T666m mutation: Hemiplegic migraine, coma, and progressive ataxia. Pediatr Neurol. 2002 26 : 47 50.
104. Tan BB. Migraine versus glaucoma-A diagnostic dilemma. Ann Acad Med Singapore. 1990 19 : 856 858.
105. Corbin D, Martyr T, Graham AC. Migraine coma. J Neurol Neurosurg Psychiatry. 1991 54 : 744.
106. Echenne B, Ducros A, Rivier F, et al Recurrent episodes of coma: An unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics. 1999 30 : 214 217.
107. Sareen D. Interesting case of migraine presenting with recurrent episodes of migraine coma. J Assoc Physicians India. 2000 48 : 1031.
108. Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. Specific kinetic alterations of human CaV2. 1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem. 2005 280 : 17678 17686.
109. Pietrobon D. Migraine: New molecular mechanisms. Neuroscientist. 2005 11 : 373 386.
110. Gursoy-Ozdemir Y, Qiu J, Matsvaka N, et al Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004 113 : 1447 1455.
111. Olesen J, Jorgensen MB. Leao's spreading depression in the hippocampus explains transient global amnesia: A hypothesis. Acta Neurol Scand. 1986 73 : 219 220.
112. Haas DC, Ross GS. Transient global amnesia triggered by mild head trauma. Brain. 1986 109 (pt2 251 257.
113. Bain PG, O'Brien MD, Keevil SF, Porter DA. Familial periodic cerebellar ataxia: A problem of cerebellar intracellular pH homeostasis. Ann Neurol. 1992 31 : 147 154.
114. Griggs RC, Moxley RT, 3rd, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: Response to acetazolamide. Neurology. 1978 28 : 1259 1264.
115. Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry. 1998 65 : 565 568.
116. Athwal BS, Lennox GG. Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol. 1996 40 : 820 821.
117. de Simone R, Marano E, Di Stasio E, Bonuso S, Fiorillo C, Bonavita V. Acetazolamide efficacy and tolerability in migraine with aura: A pilot study. Headache. 2005 45 : 385 386.
118. Vahedi K, Taupin P, Djomby R, et al Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. J Neurol. 2002 249 : 206 211.
119. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology. 2000 55 : 1588 1589.
120. Shank RP, Doose DR, Streeter AJ, Bialer M. Plasma and whole blood pharmacokinetics of topiramate: The role of carbonic anhydrase. Epilepsy Res. 2005 63 : 103 112.
121. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006 59 : 652 661.
122. Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol. 2004 56 : 213 220.
123. Jayamaha JE, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med. 1995 21 : 82 83.
124. Crawford JS, Konkol RJ. Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement. Headache. 1997 37 : 590 593.
125. Lee TG, Solomon GD, Kunkel RS, Raja S. Reversible cerebellar perfusion in familial hemiplegic migraine. Lancet. 1996 348 : 1383.
126. Harbaugh RE, Saunders RL, Reeves AG. Pediatric cerebellar infarction: Case report and review of the literature. Neurosurgery. 1982 10 : 593 596.
127. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004 291 : 427 434.
128. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005 128 : 2068 2077.
129. Duvernoy H, Delon S, Vannson JL. The vascularization of the human cerebellar cortex. Brain Res Bull. 1983 11 : 419 480.
130. Guerini D, Coletto L, Carafoli E. Exporting calcium from cells. Cell Calcium. 2005 38 : 281 289.
131. Chen G, Hanson CL, Dunbar RL, Ebner TJ. Novel form of spreading acidification and depression in the cerebellar cortex demonstrated by neutral red optical imaging. J Neurophysiol. 1999 81 : 1992 1998.
132. Ebner TJ, Chen G. Spreading acidification and depression in the cerebellar cortex. Neuroscientist. 2003 9 : 37 45.
133. Comu S, Giuliani M, Narayanan V. Episodic ataxia and myokymia syndrome: A new mutation of potassium channel gene Kv1.1. Ann Neurol. 1996 40 : 684 687.
134. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: Long-range glial signaling. Science. 1990 247 : 470 473.
135. Charles A. Intercellular calcium waves in glia. Glia. 1998 24 : 39 49.
136. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M. Signaling at the gliovascular interface. J Neurosci. 2003 23 : 9254 9262.
137. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 1994 263 : 1768 1771.
138. Dani JW, Chernjavsky A, Smith SJ. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron. 1992 8 : 429 440.
139. Newman EA, Zahs KR. Calcium waves in retinal glial cells. Science. 1997 275 : 844 847.
140. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB. ATP released from astrocytes mediates glial calcium waves. J Neurosci. 1999 19 : 520 528.
141. Kunkler PE, Kraig RP. Calcium waves precede electrophysiological changes of spreading depression in hippocampal organ cultures. J Neurosci. 1998 18 : 3416 3425.
142. Basarsky TA, Duffy SN, Andrew RD, MacVicar BA. Imaging spreading depression and associated intracellular calcium waves in brain slices. J Neurosci. 1998 18 : 7189 7199.
143. Pietrobon D. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol. 2002 25 : 31 50.
144. del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res. 2000 98 : 73 81.
145. Sappey-Marinier D, Vighetto A, Peyron R, Broussolle E, Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol. 1999 46 : 256 259.
146. Sasaki H, Kojima H, Yabe I, et al Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6). Acta Neuropathol (Berl). 1998 95 : 199 204.
147. Takahashi T, Arai N, Shimamura M, et al Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation. Neuropathology. 2005 25 : 228 234.
148. Ruskell GL, Simons T. Trigeminal nerve pathways to the cerebral arteries in monkeys. J Anat. 1987 155 : 23 37.
149. Saito K, Moskowitz MA. Contributions from the upper cervical dorsal roots and trigeminal ganglia to the feline circle of Willis. Stroke. 1989 20 : 524 526.
150. Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: Clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol. 1997 41 : 8 16.
151. Ohta M, Araki S, Kuroiwa Y. Familial occurrence of migraine with a hemiplegic syndrome and cerebellar manifestations. Neurology. 1967 17 (8pt1 813 817.
152. Young GF, Leon-Barth CA, Green J. Familial hemiplegic migraine, retinal degeneration, deafness, and nystagmus. Arch Neurol. 1970 23 : 201 209.
153. Codina A, Acarin PN, Miquel F, Noguera M. Migraine Hémiplé gique associée à un nystagmus. Rev Neurol (Paris). 1971 124 : 526 530.
154. Zifkin B, Andermann E, Andermann F, Kirkham T. An autosomal dominant syndrome of hemiplegic migraine, nystagmus, and tremor. Ann Neurol. 1980 8 : 329 332.